canlabs semaglutide FDA issues warning about some compounded versions of for diabetes, weight loss FBI issues safety warning about

Brand-name oral semaglutide (Rybelsus) is already FDA-approved for diabetes, and an oral formulation for weight loss is expanding access for patients who prefer pills over injections

If you experience side effects that you think may be related to Ozempic, you can report them through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk), which helps monitor the safety of medicines in the UK

Tirzepatide, the active ingredient in Zepbound, is already approved under the trade name Mounjaro to be used along with diet and exercise to help improve blood sugar (glucose) in adults with type 2 diabetes mellitus

Keep an eye on the retatrutide availability timeline for updates on these newer agents